Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Lucisano

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
The Journal of Clinical Endocrinology and Metabolism|February 10, 2020
Response to Letter to the Editor: "Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care"Olga Vaccaro, Antonio Nicolucci, Giuseppe Lucisano, et al.
Transfusion|February 26, 2017
Development of the Platelet Efficacy Score (PEscore) to predict the efficacy of platelet transfusion in oncohematologic patientsAnna Quaglietta, Maura Di Saverio, Giuseppe Lucisano, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 22, 2021
Effects of weight loss medications on mortality and cardiovascular events: A systematic review of randomized controlled trials in adults with overweight and obesityEsmeralda Capristo, Ausilia Maione, Giuseppe Lucisano, et al.
Plos One|August 13, 2013
Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic reviewMonica Franciosi, Giuseppe Lucisano, Emanuela Lapice, et al.
Pharmacological Research|September 15, 2018
Liraglutide and cardiovascular outcomes in a real world type 2 diabetes cohortMarco Mirani, Giuseppe Favacchio, Eliseo Serone, et al.
Acta Diabetologica|October 9, 2016
Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention StudyIrene Marzona, Fausto Avanzini, Giuseppe Lucisano, et al.
Journal of the American College of Cardiology|February 2, 2010
Cholesterol-lowering interventions and stroke: insights from a meta-analysis of randomized controlled trialsRaffaele De Caterina, Marco Scarano, Rosamaria Marfisi, et al.
Cardiovascular Diabetology|August 27, 2021
Variability in body weight and the risk of cardiovascular complications in type 2 diabetes: results from the Swedish National Diabetes RegisterAntonio Ceriello, Giuseppe Lucisano, Francesco Prattichizzo, et al.
JAMA|June 19, 2012
Association of aspirin use with major bleeding in patients with and without diabetesGiorgia De Berardis, Giuseppe Lucisano, Antonio D'Ettorre, et al.
Neuroepidemiology|December 21, 2013
Advances in meta-analysis: examples from internal medicine to neurologyMassimiliano Copetti, Andrea Fontana, Giusi Graziano, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Endocrinology and Metabolism|February 10, 2020
Response to Letter to the Editor: "Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care"Olga Vaccaro, Antonio Nicolucci, Giuseppe Lucisano, et al.
Transfusion|February 26, 2017
Development of the Platelet Efficacy Score (PEscore) to predict the efficacy of platelet transfusion in oncohematologic patientsAnna Quaglietta, Maura Di Saverio, Giuseppe Lucisano, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 22, 2021
Effects of weight loss medications on mortality and cardiovascular events: A systematic review of randomized controlled trials in adults with overweight and obesityEsmeralda Capristo, Ausilia Maione, Giuseppe Lucisano, et al.
Plos One|August 13, 2013
Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic reviewMonica Franciosi, Giuseppe Lucisano, Emanuela Lapice, et al.
Pharmacological Research|September 15, 2018
Liraglutide and cardiovascular outcomes in a real world type 2 diabetes cohortMarco Mirani, Giuseppe Favacchio, Eliseo Serone, et al.
Acta Diabetologica|October 9, 2016
Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention StudyIrene Marzona, Fausto Avanzini, Giuseppe Lucisano, et al.
Journal of the American College of Cardiology|February 2, 2010
Cholesterol-lowering interventions and stroke: insights from a meta-analysis of randomized controlled trialsRaffaele De Caterina, Marco Scarano, Rosamaria Marfisi, et al.
Cardiovascular Diabetology|August 27, 2021
Variability in body weight and the risk of cardiovascular complications in type 2 diabetes: results from the Swedish National Diabetes RegisterAntonio Ceriello, Giuseppe Lucisano, Francesco Prattichizzo, et al.
JAMA|June 19, 2012
Association of aspirin use with major bleeding in patients with and without diabetesGiorgia De Berardis, Giuseppe Lucisano, Antonio D'Ettorre, et al.
Neuroepidemiology|December 21, 2013
Advances in meta-analysis: examples from internal medicine to neurologyMassimiliano Copetti, Andrea Fontana, Giusi Graziano, et al.
Pageof 11